2018 BIO International Convention
Berlin-Brandenburg is one of the leading locations for life sciences in Europe. The Berlin biotech sector in particular has registered steady growth and high start-up dynamism. 80% of the more than 230 biotech companies work in biomedicine. They develop innovative therapeutics and diagnostics to treat cancer, cardiovascular diseases and diabetes. Benefit from the strong local research landscape, the close links between science and industry and from the excellent infrastructure for clinical trials with more than 130 clinics, including Europe's largest university hospital – the Charité.
Take advantage of the opportunity to visit the German capital region at BIO International Convention 2018 in Boston at booth #1601 in the German Pavilion. Exhibitors and representatives of the healthcare industries cluster HealthCapital will provide information about products and strengths of the life sciences region.
If you want to get in contact with companies and scientific institutes from Berlin and Brandenburg and become a partner of an active network, come to see us at our booth or in the partnering.
Contact: Cluster HealthCapital
Dr. Kai Uwe Bindseil
Contact: Investment and Relocation
Carolin Clement
Dr. Ingo Starke
Meet the following players from the German capital region at our booth:
BioGenes GmbH; Email: d.schwertner@biogenes.de
Biotechrabbit; Email: info@biotechrabbit.com
Campus Berlin-Buch; Email: cquensel@bbb-berlin.de
IGES Institute; Email: tilo.mandry@iges.com
pharmtrace clinical research; Email: eva.wellmann@pharmtrace.com
The Berlin-Brandenburg booth is funded by the states of Berlin and Brandenburg, Investitionsbank Berlin; co-financed by the European Union – European Regional Development Fund.
